Literature DB >> 18311394

A rare ovarian tumor - Sertoli-Leydig cell tumor with heterologous element.

Rimpy Tandon1, Poonam Goel, Pradip Kumar Saha, Navneet Takkar, R P S Punia.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18311394      PMCID： PMC2234306     

Source DB:  PubMed          Journal:  MedGenMed        ISSN： 1531-0132


× No keyword cloud information.
  9 in total

1.  A case of poorly differentiated Sertoli-Leydig tumor of the ovary.

Authors:  Eduardo Lara-Torre; Jennifer E Dietrich; Alan Kaplan; Henry Lopez; Ian Jaffee
Journal:  J Pediatr Adolesc Gynecol       Date:  2004-02       Impact factor: 1.814

2.  Sertoli-Leydig cell tumor.

Authors:  T Lantzsch; S Stoerer; K Lawrenz; J Buchmann; H G Strauss; H Koelbl
Journal:  Arch Gynecol Obstet       Date:  2001-01       Impact factor: 2.344

3.  Laparoscopic management of Sertoli-Leydig cell tumors of the ovary. A report of two cases.

Authors:  A Kriplani; N Agarwal; K K Roy; R Manchanda; M K Singh
Journal:  J Reprod Med       Date:  2001-05       Impact factor: 0.142

4.  Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide.

Authors:  D M Gershenson; L J Copeland; J J Kavanagh; C A Stringer; P B Saul; J T Wharton
Journal:  Obstet Gynecol       Date:  1987-11       Impact factor: 7.661

5.  Sertoli-Leydig tumors of the ovary. A clinicopathologic study of 64 intermediate and poorly differentiated neoplasms.

Authors:  C Zaloudek; H J Norris
Journal:  Am J Surg Pathol       Date:  1984-06       Impact factor: 6.394

6.  Treatment of ovarian stromal tumors.

Authors:  P E Schwartz; J P Smith
Journal:  Am J Obstet Gynecol       Date:  1976-06-01       Impact factor: 8.661

7.  Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etoposide, and cisplatin.

Authors:  D M Gershenson; M Morris; T W Burke; C Levenback; C M Matthews; J T Wharton
Journal:  Obstet Gynecol       Date:  1996-04       Impact factor: 7.661

8.  Sertoli Leydig cell tumor with heterologous gastrointestinal epithelium: a case report.

Authors:  Sandeep R Mathur; Neerja Bhatla; I Satish Rao; Manoj K Singh
Journal:  Indian J Pathol Microbiol       Date:  2003-01       Impact factor: 0.740

Review 9.  Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases.

Authors:  R H Young; R E Scully
Journal:  Am J Surg Pathol       Date:  1985-08       Impact factor: 6.394
  9 in total
  5 in total

Review 1.  Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review.

Authors:  Mariana Horta; Teresa Margarida Cunha; Rita Canas Marques; Ana Félix
Journal:  J Radiol Case Rep       Date:  2014-11-30

2.  Sertoli-leydig cell tumour of ovary with menorrhagia: a rare case report.

Authors:  Umesh Sidheshwar Kanade; Sunita Sanjay Dantkale; Rahul Ravindra Narkhede; Rupali Ramrao Kurawar; Shubhada Yadavrao Bansode
Journal:  J Clin Diagn Res       Date:  2014-10-20

3.  Uncommon indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Francis Zheng Yi Yee; Grace Hwei Ching Tan; Claramae Shulyn Chia; Khee Chee Soo; Melissa Ching Ching Teo
Journal:  Pleura Peritoneum       Date:  2017-08-24

4.  A novel clinicopathological analysis of early stage ovarian Sertoli-Leydig cell tumors at a single institution.

Authors:  Seon Mi Nam; Jee Whan Kim; Kyung Jin Eoh; Hye Min Kim; Jung Yun Lee; Eun Ji Nam; Sunghoon Kim; Sang Wun Kim; Young Tae Kim
Journal:  Obstet Gynecol Sci       Date:  2017-01-19

5.  Recurrent ovarian Sertoli-Leydig cell tumor in a child with Peutz-Jeghers syndrome.

Authors:  Edward J Bellfield; Ramin Alemzadeh
Journal:  Oxf Med Case Reports       Date:  2016-08-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.